1Ramaswami U,Whybra C,Parini R,et al.Clinical manifestations of Fabry disease in children:data from the Fabry Outcome Survey[J].Acta Paediatr,2006,95(1):86-92.
2Mehta A,Ricci R,Widmer U,et al.Fabry disease defined.baseline clinical manifestations of 366 patients in the Fabry Outcome Survey[J].Eur J Clin Invest,2004,34(3):236-242.
3Schiffmann R,Warnock DG,Banikazemi M,et al.Fabry disease:progression of nephropathy.and prevalence of cardiac and cerebrovascular events before enzyme replacementtherapy[J].Nephrol Dial Transplant,2009,24(7):2102-2111.
4Laney DA,Fernhoff PM.Diagnosis of Fabry disease via analysis of family history[J].J Genet Couns,2008,17(1):79-83.
5Eng CM,Germain DP,Banikazemi M,et al.Fabry disease:guidelines for the evaluation and management of multi-organ system involvement[J].Genet Med,2006,8(9):539-548.
6Vedder AC,Linthomt GE,Houge G,et al.Treatment of Faliry disease:outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg[J].PLoS One,2007,2(7):e598.
7Schaefer E,Mehta A,Gal A.Genotype and phenotype in Fabry disease:analysis of the Fabry outcome survey[J].Acta Paediatr Suppl,2005,94(447):87-92.